The short answer
Fenugreek in medicinal amounts warrants caution with insulin aspart. Severe low-glucose reports involved premixed insulin, but the reports do not verify aspart or establish how often the exact combination causes harm.
What this answer covers
Authenticated fenugreek seeds in traditional preparations; food seasoning differs from medicinal amounts. Premixed insulin reports are indirect for pure insulin aspart.
- Supplement or preparation
- Trigonella foenum-graecum
- Medication ingredient
- insulin aspart, human
Clinical reports describe a serious concern
Four patients using premixed insulin and fenugreek seeds had reported hypoglycemic coma. The author judged the relationship possible to probable. These observations support caution, but they lack a controlled comparison and cannot measure a rate.
Premixed insulin is not verified aspart
The inspected report does not establish that the insulin contained aspart. Even an aspart-containing premix would also have a different action profile from NovoLog or Fiasp alone, so the reports cannot define the risk of this exact pair.
Amount and preparation matter
Federal guidance warns that large fenugreek doses can cause a harmful glucose drop. Traditional seed preparations, concentrated extracts and ordinary seasoning are different exposures; no safe combination amount follows from the reports.
Use the agreed monitoring plan
Discuss the exact product and dose with the diabetes team before starting or stopping it. Follow your agreed glucose-monitoring and low-glucose treatment plan; do not adjust insulin on your own. No number of hours between the herb and insulin has been shown to remove a possible glucose interaction.
Evidence and practical considerations
Side effects & toxicity
Indirect premixed-insulin cases plus large-dose fenugreek guidance support a precaution; insulin-aspart identity and incidence unverified.
- Exact scope
- Authenticated fenugreek seeds in traditional preparations; food seasoning differs from medicinal amounts. Premixed insulin reports are indirect for pure insulin aspart. with Insulin aspart human RxCUI51428 IN; NovoLog/Fiasp formulation and subcutaneous/pump/supervised intravenous routes distinguished.
- Medication form and route
- injected insulin aspart; oral supplement
What remains uncertain
- No source-specific uncertainty removed; no invented event rate or universal insulin adjustment.
Factors that may matter: Exact insulin product; Meal pattern; Dose; Other diabetes treatment; Kidney and liver function; Supplement preparation.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People with diabetes receiving exact insulin-aspart product.
Hypoglycemia can be severe. Meal pattern, activity and added glucose-active agents affect risk. Niacin can decrease glucose-lowering effect. Mild hypoglycemia may be treated with oral glucose; severe episodes need emergency treatment.
How this applies: Exact insulin aspart formulation and route distinguished from other insulins, oral medicines and premixed products; supplement preparation and endpoint limits retained.
Not premixed insulin or all insulin analogs. Product-specific timing and device instructions apply. Fiasp niacinamide excipient is not oral pharmacologic nicotinic acid. Label rates do not measure supplement interactions.
Source 2: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People with diabetes receiving exact insulin-aspart product.
Hypoglycemia can be severe. Meal pattern, activity and added glucose-active agents affect risk. Niacin can decrease glucose-lowering effect. Mild hypoglycemia may be treated with oral glucose; severe episodes need emergency treatment.
How this applies: Exact insulin aspart formulation and route distinguished from other insulins, oral medicines and premixed products; supplement preparation and endpoint limits retained.
Not premixed insulin or all insulin analogs. Product-specific timing and device instructions apply. Fiasp niacinamide excipient is not oral pharmacologic nicotinic acid. Label rates do not measure supplement interactions.
Source 3: Original clinical case series
link.springer.com · Source check Sep 10, 2026
Population: Four people using premixed insulin and authenticated fenugreek seeds.
Hypoglycemic coma was reported; the author assessed causality as possible to probable.
How this applies: Indirect for exact insulin aspart; source medication and supplement formulation are preserved.
Premixed insulin identity is not verified as insulin aspart. Four observational reports with possible-to-probable attribution; no incidence denominator, controlled comparison or safe seed dose.
Source 4: Federal supplement guidance
nccih.nih.gov · Source check Sep 10, 2026
Population: People taking fenugreek in supplement amounts.
Large doses may cause a harmful drop in blood sugar.
How this applies: Indirect for exact insulin aspart; source medication and supplement formulation are preserved.
General guidance, not a glimepiride interaction trial or a quantified dose-response threshold. This does not establish an exact insulin-aspart interaction.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Prepared exact insulin-aspart article with product, route, botanical and clinical endpoint boundaries. | |
| Research summary published |
Article revision: aaff2b75616467fa
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.
